U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT06849791) titled 'A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult Participants' on Feb. 24.
Brief Summary: This study will assess the relative bioavailability and effect of food on pharmacokinetics of ABBV-932 oral administration in healthy adult participants.
Study Start Date: Feb. 25
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-932
Oral Capsule
DRUG: ABBV-932
Oral tablet
Recruitment Status: RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....